| Management |
|
Douglas H. Robinson, M.D.
|
|
President &
Chief Scientific Officer |
Dr. Robinson's cross-disciplinary approach to scientific study led to the development of cellular evolutionary theories and experiments culminating in the invention of deNovo Biologic's patented evolutionary bioprocess. Dr. Robinson was a principal investigator at the Naval Medical Research Institute where he developed deNovo's bioprocess under a research grant from the U.S. Office of Naval Research. In his laboratory, he developed an endothelial cell-centric molecular genetics, cell biology, cell physiology and retrovirology laboratory; studied the mechanisms of oxygen free-radical damage to brain capillary endothelial cells; and published reports in well-recognized scientific journals such as Blood and In Vitro. Collaborative investigations led to the development of a novel porcine/human bone marrow culture system, the subject of numerous publications, for which he was awarded a patent as co-inventor. Experiments using this novel bone marrow culture system were conducted on two NASA Shuttle missions. Dr. Robinson was trained in internal medicine and medical oncology at the University of Arkansas where he conducted research into the cell biology of hematopoiesis. |
| |
|
| Daniel W. Wagner |
|
| Vice President |
Mr. Wagner has over 20 years of business management experience, having worked as a management consultant at several firms, including KPMG and his own firm. He is experienced in technology transfer, systems development, management audits, and organizational analysis. Mr. Wagner was graduated Phi Beta Kappa from The Catholic University of America and received a bachelor of arts degree in economics, summa cum laude. |
| |
|
